WASHINGTON - Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.

WASHINGTON - U.S. health regulators on Thursday authorized Merck’s COVID-19 pill, known as molnupiravir — the second medication approved for at-home use to battle the rapidly-spreading omicron variant ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The Food and Drug Administration on Thursday authorized a second antiviral pill for COVID but said it should not be preferred over other treatments. The FDA cleared the pill, developed by Merck and ...

Moderna (NASDAQ:MRNA) executives emphasized the company’s evolution beyond COVID-19 vaccines during a discussion with Bernstein, highlighting its mRNA platform, personalized cancer vaccine program ...

CHICAGO, June 1 (Reuters) - Merck (MRK.N), opens new tab is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available as an Ebola treatment to ...